Investor Ideas #Potcasts #Podcast - Episode 507, #Cannabis News and #Stocks on the Move: (CSE: $PULL.C) (OTCQB: $DRVD) (CSE: $HOLL.C) (CSE: $STEM.C)
Delta, Kelowna, BC, December 15, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/121520-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/12151PULL-DRVD-HOLL-STEM.asp
Hear the investor ideas potcast on
Spotify
Hear Investor ideas cannabis potcast on iTunes
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we will be looking at a few private and public company
announcements.
Pure Extracts Technologies Corp. (CSE: PULL), a plant-based extraction company
focused on cannabis, hemp, and the rapidly emerging functional mushroom sector,
announced their support of Health Canada’s
proposed intent to revise the Special Access Programme (SAP) and related
regulations to permit certain authorized uses of psilocybin-assisted
psychotherapeutic treatments. The intended SAP revision, announced on December
11th, could lead to important new medical applications, particularly in the
complex and growing mental health sector.
Health
Canada’s announcement could act as a milestone achievement driving advanced
research initiatives forward. This includes several ongoing clinical trials
that consistently indicate breakthrough therapy potential of
psilocybin-assisted psychotherapy for a number of mental health patients suffering
from conditions where conventional therapies have failed or have proven
unsuitable.
The
proposed SAP update emphasizes the strategic importance of Pure Extracts
engagement of a globally recognized operations, compliance, and regulatory
consulting firm to advise on the Company’s application to Health Canada for a
Dealers Licence under the Controlled Drugs and Substances Act (CDSA). The CDSA
and its Regulations provide the framework for legal access to controlled
substances, and the control and regulation of production, distribution, and
sale. One of Health Canada’s responsibilities is to provide the licensing and
oversight framework for the legal production of controlled substances.
Upon
acceptance, a Dealer’s License could allow Pure Extracts to engage in the
following activities:
● Procurement
of controlled substances, including by import, synthesis, propagation,
cultivation and harvesting of psychedelic mushrooms for psilocybin extraction
●
Research and manufacture of controlled
substances such as psilocybin and psilocin
●
Business to business sale of controlled
substances, including by export
● Sale of
controlled substance via pharmacies
Expanding
upon the strategic importance of the SAP review, Pure Extracts recently
announced a collaboration with Dr. Alexander MacGregor as a key scientific
advisor to the Company. Pure Extracts and Dr. MacGregor are collaborating on
the development and research of optimum psilocybin extraction methodologies in
preparation to service the needs of the rapidly advancing growth and demand in
the sector.
As
previously noted, Dr. MacGregor is the Dean of Faculty, a distinguished
Professor of Biopharmaceutics, and current President of the Toronto Institute
of Pharmaceutical Technology (TIPT) – North America’s premier post-graduate
institute of pharmaceutical sciences, technology and research. He is also the
CEO of TIPT’s parent company, Transpharm Canada Inc., which holds a Health
Canada Drug Establishment License, a Cannabis Drug License, and a Dealer’s
License issued under the Controlled Drugs and Substances Act (CDSA). Transpharm
Canada conducts clinical trials, drug development and is licensed to possess
psychedelic drug compounds.
Pure
Extracts CEO Ben Nikolaevsky states, “The Special Access Programme may prove to
be the tipping point and fundamental milestone event that eventually transforms
an entire segment of the medical community’s outlook towards the treatment of
mental health conditions. With greater and more open access to trials,
researchers can move towards larger and more comprehensive studies eventually
including thousands of patient candidates. Through multiple large-scale
studies, we see great promise in determining treatment safety, efficacy, and
desired outcomes. Our research suggests a broad spectrum of products
encompassing multiple formulations will be required to service demand across
potentially intensive therapies through to microdosing protocols. Exact
formulations and high-quality products will be required, and that is
fundamentally the sort of work we understand and excel at. Here at Pure
Extracts, we believe in the future of the mushroom-based drug development
sector and are committed to building value based on the growing number of
positive indicators for future success.”
Driven Deliveries, Inc. (OTCQB: DRVD), one of California's
fastest-growing e-commerce cannabis retailers and direct-to-consumer logistics
companies, today announced it has secured preliminary
approval for a new e-commerce delivery hub in the Fresno County region. Driven has also submitted its application for
this new cannabis non-storefront retail license to the State of California
which is expected to be approved in the near-term. Plans for Driven's acquisition by Stem Holdings, Inc. (OTCQX: STMH) (CSE: STEM) later this month are continuing on
schedule, creating Driven By Stem trading
under Stem's current symbols.
This new
strategically-located hub will enable Driven to serve central California with
greater efficiency and speed, and will be led by key experienced employees
transferring to this location to ensure a smooth and flawless launch. This is expected to create 50 new jobs in the
local area and afford significant cost savings in both general and
administrative costs, as well as local taxes, with savings of $1.2 million
annually vs. servicing this market from a remote hub.
"Securing a license in Central California
is a key component in Driven's focus on building market share with increasing
operational efficiencies in new and current markets," commented Salvador
Villanueva, interim CEO of Driven, and founder of its Budee e-commerce brand
acquired earlier this year. "Our
focus on expanding our footprint in California with our Budee and Ganjarunner
e-commerce stores as well as new markets will be the key to driving
profitability in 2021," he concluded.
"We
are pleased that this first step in our plan to integrate Driven into Stem's
operations is nearing completion," stated Adam Berk, CEO of Stem
Holdings. "Sal and the team have
made great strides over the last 60 days as part of our 'On Your Mark'
initiative to prepare for a seamless assimilation of Driven that will quickly
build value for our shareholders," he remarked.
Driven
currently has delivery hubs located in Oakland and Los Angeles, California, and
will be expanding to the Oregon market in which Stem already operates by
year-end.
Hollister
Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) has its roots in the birthplace of
the American biker, and Easyriders has been the definitive voice of motorcycle
culture for half a century. As part of Easyriders' 50th-anniversary
celebration, the Company signed an exclusive agreement with
Hollister Biosciences to introduce a national line of cannabis products that
embody the biker spirit and ethos. It is
anticipated that the new line will make its debut next month with pre-rolls and
mini pre-rolls, followed by a cannabis tattoo balm that's applied directly to
the skin after new ink, with a full line of products coming in 2021.
The Company feels the market
potential for these products is significant, but so is the cultural
significance considering the two companies involved.
Easyriders magazine debuted shortly
after the groundbreaking 1969 film Easy
Rider in which Peter Fonda and Dennis Hopper portray bikers traveling across
the American Southwest. Similarly, Hollister Biosciences is based in Hollister,
California, home to an infamous 1947 biker rally that birthed the outlaw biker
image and inspired the Marlon Brandon film The
Wild One. Cannabis, which had developed its own outlaw culture a few
decades before, became a staple among bikers in the late '60s onward. As
epitomized in the pages of Easyriders, this vibrant biker culture grew beyond
its outlaw origins to inspire an independent spirit that embraces exploration,
Americana and the sense of freedom that only comes from riding.
This is a culture that accepts
nothing less than total authenticity. That includes its choice in cannabis, and
that is why Hollister Biosciences and Easyriders were destined to take this
ride together. From their historic roots in biker culture to their embrace of
its visual iconography, these companies will offer the first truly authentic
cannabis products for one of the most iconic cultures in modern American
history.
"My vision for Hollister has
always been to pay homage to the amazing biker culture that has permeated the
global landscape over the past few decades by combining it with amazing
cannabis products," says Carl Saling, the Co-Founder, CEO and Director of
Hollister Biosciences. "Easyriders is one of the most iconic and
recognizable global biker brands. We are proud to be their exclusive cannabis
partner, and we look forward to producing a truly authentic experience across
the cannabis SKUs we develop and distribute across America."
Hollister Biosciences, whose
products are currently found in nearly 300 dispensaries in California and more
than 80 in Arizona, takes a seed-to-shelf approach that carefully scales up
small-farm style production that meets the highest quality standards. As part
of the new agreement, the company will introduce Easyriders pre-rolls and
tattoo balms into the California market in early 2021 with a full line of
products to follow. Like an eastbound ride on Route 66, Arizona comes next, and
the rest of the American markets will follow.
Pepper Foster, President of
Easyriders, stated, "My vision for Easyriders has been to pay homage to
the 50 years of this iconic magazine and to Joe Teresi who launched Easyriders
in the late 1960s. The first magazine hit the stands in June 1970, and 50 years
later, we are proud to carry the torch, expanding upon that yen to be devoid of
restraint by taking a broader look at what it means to be a biker in the 21st
century while staying connected to our original roots. In continuing our
commitment to authenticity, we are proud and excited to partner with another
iconic brand, Hollister. We invite you to take the ride with us. Ride hard.
Ride fast."
The terms of the deal are; 2-year
exclusive agreement on all cannabis products in the US with an 80:20 net
revenue split in favour of Hollister with options to renew for subsequent
terms.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investors can trade
these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and
others.
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor
Ideas – news, articles, podcasts and stock
directory
No comments:
Post a Comment